The Research & Development team at Gubra is dedicated to advancing the company's proprietary early target and drug discovery programs, with a strong focus on metabolic diseases such as obesity, diabetes, NASH, and gastrointestinal disorders. This multidisciplinary team, including experts in pharmacology, computational biology, chemistry, bioanalysis, and imaging, works collaboratively to design and execute high-quality research projects. They leverage state-of-the-art techniques in peptide chemistry, in vivo and ex vivo assays, molecular pharmacology, and bioinformatics to drive scientific innovation and support the development of novel therapeutics.